Keyphrases
Route of Administration
100%
Immunogenicity
100%
Peptide Vaccine
100%
Cancer Peptide Vaccine
100%
Cytotoxic T Cell Response
50%
Poly IC
25%
Tumor
25%
Antibody Response
25%
Immunogen
25%
Clinical Setting
25%
Cytotoxic T Lymphocyte Epitope
25%
Synthetic Peptides
25%
Antitumor Effect
25%
Measurable Disease
25%
Poor Performance
25%
Intravenous Route
25%
Subcutaneous Injection
25%
Positive Impact
25%
Long Peptides
25%
Amphiphilic
25%
Cost-effective Approach
25%
Freund's Adjuvant
25%
Immunization Programs
25%
Peptide Construct
25%
Palmitoylated Peptide
25%
Vogue
25%
Pharmacology, Toxicology and Pharmaceutical Science
Route of Administration
100%
Immunogenicity
100%
Tumor Vaccine
100%
Peptide Vaccine
100%
Malignant Neoplasm
50%
Neoplasm
25%
Polypeptide
25%
Epitope
25%
Subcutaneous Injection
25%
Synthetic Peptide
25%
Freund's Adjuvant
25%
Intravenous Route
25%
Carboxymethylcellulose Polycytidylic Polyinosinic Acid Polylysine
25%
Diseases
25%
Immunology and Microbiology
Immunogenicity
100%
Peptide Vaccine
100%
Tumor Vaccine
100%
Peptides
100%
Cytotoxic T Cell
75%
Epitope
25%
Antibody Response
25%
Freund's Adjuvant
25%
Carboxymethylcellulose Polycytidylic Polyinosinic Acid Polylysine
25%